Evidence map›Paper›PMID 25347005›Full record

Trial reportBone marrow transplantation2015

Predictive role of levels of soluble interleukin-2 receptor and C-reactive protein in selecting autologous PBSC transplantation for lymphoma.

H Ariizumi, B Saito, Y Uto, N Hattori, H Nakashima, K Yanagisawa, H Harada, H Mori, T Nakamaki

Abstract readClinical TrialLetterMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Bone marrow transplantation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Comprehensive serum cytokine analysis identifies IL-1RA and soluble IL-2Rα as predictors of event-free survival in T-cell lymphoma.Annals of oncology : official journal of the European Society for Medical Oncology · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

H AriizumiDivision of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
B SaitoDivision of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Y UtoDivision of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
N HattoriDivision of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
H NakashimaDivision of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
K YanagisawaDivision of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
H HaradaDivision of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
H MoriDivision of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
T NakamakiDivision of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Peripheral Blood Stem Cell TransplantationAdultAgedAutograftsC-Reactive ProteinDisease-Free SurvivalFemaleHumansLymphoma, Non-HodgkinMaleMiddle AgedPredictive Value of TestsReceptors, Interleukin-2Survival RateC-Reactive ProteinReceptors, Interleukin-2

Identifiers

PMID25347005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.